Does analgesic overuse matter? Response to OnabotulinumtoxinA in patients with chronic migraine with or without medication overuse
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://link.springer.com/content/pdf/10.1186/s40064-015-1386-8.pdf
Reference32 articles.
1. Ahmed F, Khalil M (2013) Hull headache diary. http://www.bash.org.uk/about/headache-diary/
2. Aoki KR (2005) Review of a proposed mechanism for the antinoceceptive action of botulinum toxin type A. Neurotoxicology 26:785–793
3. Aurora SK, Dodick DW, Turkel CC, DeGryse RE, Silberstein SD, Lipton RB, Deiner HC, Brin MF, PREEMPT I Chronic Migraine Study Group (2010) OnabotulinumtoxinA for treatment of chronic migraine; results from the double-blind, randomised, placebo-controlled phase of the PREEMPT I trial. Cephalalgia 30:793–803
4. Aurora SK, Winner P, Freeman MC, Spierings EL, Heiring JO, DeGryse RE, VanDenburgh AM, Nolan ME, Turkel CC (2011) OnabotulinumtoxinA for treatment of chronic migraine: pooled analyses of the 56-week PREEMPT clinical program. Headache 51:1358–1373
5. Bigal ME, Rapoport AM, Sheftell FD, Tepper SJ, Lipton RB (2004) Transformed migraine and medication overuse in a tertiary headache centre—clinical characteristics and treatment outcomes. Cephalalgia 2004(24):483–490
Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Insights from 25 years of onabotulinumtoxinA in migraine — mechanisms and management;Nature Reviews Neurology;2024-08-19
2. Treatment of chronic migraine with Botox (onabotulinumtoxinA): Development, insights, and impact;Medicine;2023-07-01
3. OnabotulinumtoxinA: Still the Present for Chronic Migraine;Toxins;2023-01-10
4. Effectiveness and Safety of Chronic Migraine Preventive Treatments: A Systematic Literature Review;Pain and Therapy;2022-11-22
5. Effectiveness of onabotulinumtoxinA (BOTOX®) for the preventive treatment of chronic migraine: A meta-analysis on 10 years of real-world data;Cephalalgia;2022-09-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3